# The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects

> **NCT01346657** · PHASE4 · COMPLETED · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 14 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Nifidipine & LipoCol

## Key facts

- **NCT ID:** NCT01346657
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01346657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01346657, "The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01346657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*